BTK Inhibitors in CLL and Lymphomas: Overview and Current Indications

Decera Clinical Education Oncology Podcast · Jul 23, 2021 · 13m

In this podcast episode, Beth Faiman, PhD, MSN, APRN-BC, AOCN, provides a nursing-focused overview on available BTK inhibitors in the treatment of CLL and lymphomas. Topics in this podcast include:

Rationale for inhibiting BTK

MOA of BTK inhibitors

Approved BTK inhibitors

Recent clinical trial findings

Link to full program, including downloadable slidesets:

https://bit.ly/3iwN9Ub

Presenter:

Beth Faiman, PhD, MSN, APRN-BC, AOCN

Nurse Practitioner

Cleveland Clinic Taussig Cancer Institute

Cleveland, Ohio

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our…